These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 15016014)

  • 21. [Hyperammonemic encephalopathy associated with valproate acid].
    Osuna MT; Burcet J; Ramió L; Ustrell X; Silva Y; Molins A
    Neurologia; 2003; 18(6):347-50. PubMed ID: 12838456
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hyperammonemic encephalopathy induced by valproic acid.
    Zhu QM; Singh AK; Chang HR; Konka SA
    BMJ Case Rep; 2024 Feb; 17(2):. PubMed ID: 38350699
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hyperammonemic coma after craniotomy: Hepatic encephalopathy from upper gastrointestinal hemorrhage or valproate side effect?: Case report and literature review.
    Guo X; Wei J; Gao L; Xing B; Xu Z
    Medicine (Baltimore); 2017 Apr; 96(15):e6588. PubMed ID: 28403092
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Valproic acid-induced hyperammonemic encephalopathy in a full-term neonate: a brief review and case report.
    Pokorná P; Hronová K; Šíma M; Slanař O; Klement P; van den Anker JN; Tibboel D
    Eur J Clin Pharmacol; 2017 May; 73(5):647-649. PubMed ID: 28168312
    [No Abstract]   [Full Text] [Related]  

  • 25. Valproate Induced Hyperammonemic Encephalopathy.
    Qayyum W; Yousafzai ZA; Iqbal MS; Khan S; Amin QK; Shafiqs I
    J Ayub Med Coll Abbottabad; 2022; 34(Suppl 1)(4):S1038-S1039. PubMed ID: 36550671
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Valproate-induced hyperammonemic encephalopathy: a case report and brief review of the literature.
    Sunkavalli KK; Iqbal FM; Singh B; Koneru J
    Am J Ther; 2013; 20(5):569-71. PubMed ID: 21248614
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Valproate-induced hyperammonemic encephalopathy].
    Granel B; Gavaret M; Le Baut X; Sautereau N; Rodriguez D; Rossi P; Bagnères D; Demoux AL; Francès Y
    Rev Med Interne; 2011 Jun; 32(6):e72-5. PubMed ID: 20633966
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The decreased level of plasma carnitine in patients with epilepsy].
    Belousova ED
    Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(6):106-110. PubMed ID: 28745680
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Valproate induced non hepatic hyperammonaemic encephalopathy (VNHE)--a study from tertiary care referral university hospital, north India.
    Mehndiratta MM; Mehndiratta P; Phul P; Garg S
    J Pak Med Assoc; 2008 Nov; 58(11):627-31. PubMed ID: 19024136
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Non-convulsive status epilepticus secondary to valproic acid-induced hyperammonemic encephalopathy.
    Velioğlu SK; Gazioğlu S
    Acta Neurol Scand; 2007 Aug; 116(2):128-32. PubMed ID: 17661800
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reversible Encephalopathy due to Valproic Acid Induced Hyperammonemia in a Patient with Bipolar I Disorder: A Cautionary Report.
    Patel N; Landry KB; Fargason RE; Birur B
    Psychopharmacol Bull; 2017 Jan; 47(1):40-44. PubMed ID: 28138203
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Valproate-induced hyperammonemic encephalopathy. Review of cases in the psychiatric setting].
    Fassi G; Igoa A; Liste OA
    Vertex; 2008; 19(82):371-7. PubMed ID: 19424520
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Incidence, Presentation, and Risk Factors for Sodium Valproate-Associated Hyperammonemia in Neurosurgical Patients: A Prospective, Observational Study.
    Woo PYM; Woo AWY; Lam SW; Ko NMW; Ho JWK; Chu ACH; Kwan MCL; Chan Y; Wong HT; Chan KY
    World Neurosurg; 2020 Dec; 144():e597-e604. PubMed ID: 32916358
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Valproate-induced hyperammonemic encephalopathy: a case report.
    Shah S; Wang R; Vieux U
    J Med Case Rep; 2020 Jan; 14(1):19. PubMed ID: 31980035
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A case of valproate-induced hyperammonaemic encephalopathy.
    Lucie O; Nazir F; Spilg E
    Scott Med J; 2013 Feb; 58(1):e43-4. PubMed ID: 23596040
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Valproate-induced hyperammonemic encephalopathy.
    Murphy JV
    Epilepsia; 2003 Feb; 44(2):268; author reply 268. PubMed ID: 12558587
    [No Abstract]   [Full Text] [Related]  

  • 37. Topiramate increases the risk of valproic acid-induced encephalopathy.
    Noh Y; Kim DW; Chu K; Lee ST; Jung KH; Moon HJ; Lee SK
    Epilepsia; 2013 Jan; 54(1):e1-4. PubMed ID: 22691153
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Valproic acid induced encephalopathy--19 new cases in Germany from 1994 to 2003--a side effect associated to VPA-therapy not only in young children.
    Gerstner T; Buesing D; Longin E; Bendl C; Wenzel D; Scheid B; Goetze G; Macke A; Lippert G; Klostermann W; Mayer G; Augspach-Hofmann R; Fitzek S; Haensch CA; Reuland M; Koenig SA
    Seizure; 2006 Sep; 15(6):443-8. PubMed ID: 16787750
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Valproate (VPA)-associated hyperammonemic encephalopathy independent of elevated serum VPA levels: 21 cases in China from May 2000 to May 2012.
    Cheng M; Tang X; Wen S; Yue J; Wang H
    Compr Psychiatry; 2013 Jul; 54(5):562-7. PubMed ID: 23246073
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Valproate-Induced Hyperammonemic Encephalopathy in General Hospital Patients With One or More Psychiatric Disorders.
    Lewis C; Tesar GE; Dale R
    Psychosomatics; 2017; 58(4):415-420. PubMed ID: 28411969
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.